Consolidative radiation in the management of relapsed/refractory Hodgkin lymphoma: a single institution study
{{output}}
Background: 5-30% of Hodgkin Lymphoma (HL) patients are refractory to primary therapy or have disease relapse requiring additional salvage treatment. High-dose chemotherapy with autologous stem cell transplant (ASCT) is the curre... ...
